Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
SinocellTech 2026 Company Profile: Stock Performance & Earnings | PitchBook
The Sinocelltech - 2026 Company Profile, Team, Funding & Competitors ...
Sinocelltech | Biotechnology, Health Care, Manufacturing, Medical ...
Qiming and SinoCellTech announce malignant solid tumors treatment ...
Las ETF que invierten en acciones de Sinocelltech Group Limited Class A ...
Sinocelltech biosimilar Adalimumab launched, based on significant cost ...
Sinocelltech Group (688520SS) VRIO Analysis – DCFmodeling.com
PESTEL Analysis of Sinocelltech Group (688520SS) – DCFmodeling.com
Sinocelltech Group Ltd. - Drug pipelines, Patents, Clinical trials ...
Sinocelltech Recombinant factor VIII start to sell in China market
Sinocelltech Group (688520SS) DCF Excel Template – DCFmodeling.com
Sinocelltech Gains NMPA Clearance for SCTB39-1 Clinical Study in ...
Sinocelltech Recombinant Factor VIII get the highest priority by Turkey ...
sinocelltech pipeline. 2 products will be launched this year. one is ...
Sinocelltech Wins NMPA Clearance for TriAb SCTB39G in Solid Tumors ...
Sinocelltech Group And 2 More High Growth Tech Stocks In Asia
Sinocelltech renoue avec les bénéfices au premier semestre ; les ...
Qiming-backed pharma firm Sinocelltech to raise $181m in STAR Market IPO
SINOCELLTECH GROUP AKTIE Chart | Chartanalyse | Indikatoren | A40R95
Sinocelltech Group Limited
Jian Li - Sinocelltech Ltd.Co | 领英
Recombinant facor VIII of sinocelltech got GMP certification from ...
Dialogue with CEO: SinoCellTech - Exploring the Ultimate Advantages of ...
Sinocelltech Group Ltd. (北京神州细胞生物技术集团股份公司) - 药物管线_专利_临床试验_投融营收_最新药物:菲诺利 ...
Frank Lai on LinkedIn: Sinocelltech plant successfully passed Brazil ...
Frank Lai on LinkedIn: Sinocelltech biosimilar Bevacizumab launched ...
Ying Chen - Director of Government Affairs at Sinocelltech Group Ltd ...
Sinocelltech Group Limited (688520.SS) Stock Price, News, Quote ...
SinocellTech’s Recombinant Protein COVID-19 Vaccine SCTV01C Approved ...
Private Equity_Huizhi Group|Huiyu Investment
Sinocell Technology | LinkedIn
神州细胞
SinoCell Technologies - Biobanking.com
2价变异株新冠疫苗(SCTV01C) 临床研究国内外同步推进!_神州细胞
SinoCellTech's SCT640C Injection Receives NMPA Approval for RA Clinical ...
SinocellTech's PD-1 combo therapy approved for HCC by NMPA | Qiming ...
SinocellTech's SCT-I10A combination therapy for HNSCC | Qiming Venture ...
Beijing Starts Using Sinocelltech’s Recombinant Covid-19 Vaccine
Sinocelltech, Clover Soar as Vaccine Makers’ Covid-19 Jabs Are Approved ...
Category:SinoCellTech - Wikimedia Commons
Sinocelltech’s SCT-800 wins NMPA approval; first homegrown drug for ...
Qiming Venture Partners on LinkedIn: #portfolionews #sinocelltech # ...
#sinocelltech #sctv01e #vaccine #qmportfolio #qmhealthcare | Qiming ...
阿达木单抗生物类似药 (神州细胞工程)(Adalimumab biosimilar (Sinocelltech Group))-药物靶点 ...
Frank Lai on LinkedIn: another product of Sinocelltech, Ripertamab ...
Bo Zhong - Sinocelltech, Ltd | 领英
北京神州细胞生物技术集团股份公司 (Sinocelltech Group Limited) 公司概况 - 中国 | 财务及主要执行人员 | EMIS
神州细胞sinocelltech 别来 - 知乎
Beijing E-Town listed companies report impressive Q1 results
神州细胞针对XBB/BQ1.1等变异株的四价新冠疫苗纳入紧急使用_神州细胞
再传佳因|安佳因®上市一周年庆典_神州细胞
Qiming Venture Partners on LinkedIn: #portfolioawards #biomedical # ...
Applitech M control is a powerful and efficient tool for the ...
首页
奥密可戎可能感染90%的人,放开管控后新冠疫苗该怎么选? - 脉脉
神州细胞 SinoCollTech-罐头图库
神州细胞新冠疫苗SCTV01C广谱性优势研究论文正式发表_神州细胞
Richest scientists in the world 2023
神州细胞新冠重组蛋白二价疫苗获得第二剂次加强免疫接种方案推荐_神州细胞
Evolving Treatment Market Dynamics of EGFR-NSCLC | Key Insights
从头颈鳞癌到肝癌!安佑平®获批两大适应症_神州细胞
安贝珠®——神州细胞贝伐珠单抗注射液获批上市_神州细胞
Immunogenicity Assessment of a 14-Valent Human Papillomavirus Vaccine ...
神州细胞被授予“第六届中阿博览会数宇健康展览展示暨大健康产业论坛支持单位”荣誉称号_神州细胞
CrossNow
Frontiers | A novel bispecific antibody dual-targeting approach for ...
唯一针对变异株的4价疫苗,全面开始接种!_神州细胞
Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 ...
一线“佑”选,安护新生——安佑平®获批用于全人群复发/转移性头颈部鳞癌治疗_神州细胞
Sinotech Lab Scale Bioreactor Fermenter for Solids with Bioreactor ...
Current status and future directions for the development of human ...